B+
Bull case
20%
Probability
Target price
$22.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
DBVT
DBVDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
DBV has a defined near-term regulatory milestone, constructive FDA engagement, no reported request for additional data, and runway into Q3 2027. Successful BLA filing and eventual approval could materially improve the valuation.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +4.0.
What can break
BLA submission could be delayed or require further regulatory work.
Momentum
10
Value
41
Sentiment
62
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.50 · Bull $22.00 · Bear $7.50Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $39.84
Why
Momentum10 · Δ7d -6.4
Value41 · Δ7d -0.0
Sentiment62 · Δ7d +4.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +4.0.
Contradictions & invalidation
- • BLA submission could be delayed or require further regulatory work.
- • Clinical, CMC, biostatistical, and manufacturing execution risks remain.
- • The thesis remains binary: filing timing, FDA review, approval, and commercial execution are not assured.
Catalyst clock
2026-11-02
Q3 2026 optimized BLA submission
Lead driver: Sentiment · See AI snapshot
Momentum
10
9% active weight
Current posture
7d trendSoftening
Δ7d
-6.4
Δ21d
+0.0
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
62
62% active weight
Current posture
7d trendImproving
Δ7d
+4.0
Δ21d
+10.6
Why this grade
Composite grade D. Momentum 9.5 / Value 41.2 / Sentiment 61.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$12.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$935.38M
Beta
-0.79
Shares Out
62.85M
P/E (TTM) · Derived
-2.8
P/S (TTM)
185.76
P/FCF (TTM) · Derived
-4.50
Rev YoY
+158.8%
EPS YoY
-63.2%
Gross Margin
-958.2%
Op Margin
-2287.2%
Net Debt
-$172.48M
Current Ratio
3.72
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data